| Drug Name: | Salmeterol (89365-50-4) |
|---|---|
| PubChem ID: | 5152 |
| SMILES: | C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O |
| InchiKey: | GIIZNNXWQWCKIB-UHFFFAOYSA-N |
| Therapeutic Category: | Adrenergic Agents, Adrenergic Agonists, Adrenergic beta-2 Receptor Agonists, Adrenergic beta-Agonists, Anti-Asthmatic Agents, Autonomic Agents, Bronchodilator Agents, Neurotransmitter Agents, Peripheral Nervous System Agents, Respiratory System Agents |
| Molecular Weight (dalton) | : | 415.574 |
| LogP | : | 4.1074 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 5 |
| Hydrogen Bond Donor Count | : | 4 |
| Total Polar Surface Area | : | 81.95 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Cardiovascular Effects | Beta-2 adrenergic receptor (P07550) | Bronchodilatation@ susceptibility to aGOnist-induced desensitization@cardiovascular effects [ ADR Type 1 ] | Beta2-adrenergic receptor genetics |
| Desensitization Cardiovascular Effects | Beta-2 adrenergic receptor (P07550) | Bronchodilatation@ susceptibility to aGOnist-induced desensitization@cardiovascular effects [ ADR Type 1 ] | Beta2-adrenergic receptor genetics |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category